Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Cytosorbents Corporation (CTSO)

4.5400 -0.0048 (-0.11%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
37,216
37,063
35,595
31,084.9530
29,359.9100
Cost of Revenue
10,567
10,572
10,708
9,131.7160
13,955.7520
Gross Profit
26,649
26,491
24,887
21,953.2370
15,404.1580
Operating Expense
38,758
40,730
41,339
53,901.8570
46,926.0370
Operating Income
-12,109
-14,239
-16,452
-31,948.6200
-31,521.8790
Net Non Operating Interest Income Expense
-3,117
-2,612
-1,399
-157.8910
132.5970
Other Income Expense
-3,389
8,252
-4,559
2,046.0120
-2,515.8860
Pretax Income
-18,615
-8,599
-22,410
-30,060.4990
-33,905.1680
Tax Provision
--
-401
-1,691
-813.7390
-1,092.5850
Net Income Common Stockholders
-18,214
-8,198
-20,719
-29,246.7600
-32,812.5830
Diluted NI Available to Com Stockholders
-18,214
-8,198
-20,719
-29,246.7600
-32,812.5830
Basic EPS
-5.80
-2.60
-7.60
-13.00
-14.93
Diluted EPS
-5.80
-2.60
-7.60
-13.00
-14.93
Basic Average Shares
3,139.0210
3,111.5880
2,721.7300
2,232.8190
2,189.4990
Diluted Average Shares
3,139.0210
3,111.5880
2,721.7300
2,232.8190
2,189.4990
Total Operating Income as Reported
-12,929
-14,749
-16,452
-31,948.6200
-31,521.8790
Total Expenses
49,325
51,302
52,047
63,033.5730
60,881.7890
Net Income from Continuing & Discontinued Operation
-18,214
-8,198
-20,719
-29,246.7600
-32,812.5830
Normalized Income
-15,384
-16,594.8830
-16,812.8075
-31,143.3871
-30,442.3547
Interest Expense
3,117
2,612
1,399
157.8910
--
Net Interest Income
-3,117
-2,612
-1,399
-157.8910
132.5970
EBIT
-15,498
-5,987
-21,011
-29,902.6080
-31,521.8790
EBITDA
-13,960
-4,356
-19,267
-27,879.1860
-30,390.2500
Reconciled Cost of Revenue
10,567
10,572
10,708
9,131.7160
13,955.7520
Reconciled Depreciation
1,538
1,631
1,744
2,023.4220
1,131.6290
Net Income from Continuing Operation Net Minority Interest
-18,214
-8,198
-20,719
-29,246.7600
-32,812.5830
Total Unusual Items Excluding Goodwill
-2,830
8,811
-4,225
1,949.2570
-2,448.5830
Total Unusual Items
-2,830
8,811
-4,225
1,949.2570
-2,448.5830
Normalized EBITDA
-11,130
-13,167
-15,042
-29,828.4430
-27,941.6670
Tax Rate for Calcs
0
0
0.0001
0
0
Tax Effect of Unusual Items
0
414.1170
-318.8075
52.6299
-78.3547
12/31/2022 - 8/8/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: